Medipal Holdings Corporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medipal Holdings with three other
companies in this sector in Japan:
Suzuken Co., Ltd.
sales of 2.13 trillion Japanese Yen [US$19.64 billion]
of which 93%
was Pharmaceutical Wholesale Business),
Toho Holdings Company Limited
(1.22 trillion Japanese Yen [US$11.26 billion]
of which 92%
was Pharmaceutical Wholesale Business), and
Alfresa Holdings Corporation
(2.64 trillion Japanese Yen [US$24.32 billion]
of which 88%
was Wholesale Business of Pharmaceuticals fo).
Medipal Holdings reported sales of ¥3.18 trillion (US$29.31 billion)
March of 2019.
a very small
increase of 1.1%
versus 2018, when the company's sales were ¥3.15 trillion.
This was the fourth straight year of sales growth at Medipal Holdings.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Medipal Holdings had sales
of ¥2.95 trillion.
Sales of Daily Necessities, Cosmetics, Pharmaceut saw an increase
that was more than double the company's growth rate: sales were up
5.0% in 2019, from
¥966.17 billion to ¥1.01 trillion.
Medipal Holdings also saw significant increases in sales in
Related Business (up 4.9% to ¥66.19 billion)
Not all segments of Medipal Holdings experienced an increase in sales in 2019:
sales of Pharmaceuticals and Food Precessing Whol fell 0.8% to ¥2.10 trillion.